Skip to main content

Table 4.

Thymus, spleen, mesenteric lymph nodes, and peripheral blood immune cell phenotype of DR.lepr−/lepr− line

DR.+/+ DR.lepr−lepr− P
Thymus
DN 5.35 ± 1.1 8.06 ± 2.8 ns
DP 82.04 ± 0.8 78.18 ± 2.4 *
CD4+ 7.89 ± 0.7 10.03 ± 0.5 *
CD8+ 4.73 ± 0.6 3.73 ± 0.3 *
R73+ 94.55 ± 0.9 89.50 ± 2.6 *
CD4+CD25+ 0.89 ± 0.2 0.79 ± 0.1 ns
CD90+ 97.31 ± 1.1 93.25 ± 2.8 *
CD45+CD45RA+ 0.63 ± 0.2 0.49 ± 0.1 ns
CD45+CD45RC+ 0.72 ± 0.1 0.87 ± 0.2 ns
CD45+ 97.08 ± 1.1 93.99 ± 3.4 ns
Spleen
R73+ 25.08 ± 1.5 20.25 ± 1.7 *
R73+CD4+ 63.41 ± 1.7 67.99 ± 1.4 *
R73+CD8+ 27.59 ± 1.1 21.03 ± 1.2 *
R73+CD4+CD8+ 4.18 ± 0.3 5.98 ± 0.6 *
R73+CD4CD8 3.98 ± 0.4 2.45 ± 0.2 *
CD4+CD25+ 3.14 ± 0.3 3.21 ± 0.4 ns
CD90+ 29.55 ± 2.4 24.93 ± 1.5 *
CD45+CD45RA+ 42.23 ± 2.5 32.32 ± 1.1 *
CD45+CD45RC+ 30.85 ± 2.6 19.15 ± 1.1 *
CD45+ 92.25 ± 1.6 84.86 ± 2.7 *
MLN
R73+ 75.30 ± 3.9 77.20 ± 7.5 ns
R73+CD4+ 77.98 ± 6.3 76.07 ± 3.0 ns
R73+CD8+ 14.66 ± 4.5 14.39 ± 3.7 ns
R73+CD4+CD8+ 2.26 ± 0.4 3.39 ± 0.8 *
R73+CD4CD8 1.71 ± 0.2 1.66 ± 0.6 ns
CD4+CD25+ 6.03 ± 1.1 6.66 ± 0.7 ns
CD45+CD45RA+ 18.29 ± 3.5 17.31 ± 2.5 ns
CD45+CD45RC+ 20.60 ± 3.3 19.91 ± 2.4 ns
CD45+ 98.05 ± 1.6 96.93 ± 2.5 ns
Peripheral blood
R73+ 31.08 ± 4.8 19.83 ± 6.7 ns
R73+CD4+ 80.25 ± 2.3 78.52 ± 1.9 ns
R73+CD8+ 16.31 ± 3.2 14.60 ± 3.9 ns
R73+CD4+CD8+ 1.75 ± 0.3 3.09 ± 0.4 *
R73+CD4CD8 0.93 ± 0.4 0.69 ± 0.0 ns
CD4+CD25+ 0.95 ± 0.3 1.20 ± 0.1 ns
CD45+CD45RA+ 12.93 ± 1.4 13.13 ± 4.3 ns
CD45+CD45RC+ 19.25 ± 2.7 19.10 ± 5.1 ns
CD45+ 33.83 ± 7.1 38.40 ± 7.1 ns

Data are from male and female rats and represent means ± SD for n = 4/group for each genotype. Values are the proportion (%) of the total gated cells as determined by immunofluorescence. MLN, mesenteric lymph node. Differences among DR.+/+ control and DR.lepr−/lepr− rats were determined by Student's t-test.

*

P < 0.05.